Trials / Not Yet Recruiting
Not Yet RecruitingNCT07005648
Brazilian Registry of Menopausal Health
Population-based Cross-sectional Observational Study for a Brazilian Registry of Menopausal Women and Associated Factors Related to Clinical Profile, Socioeconomic Aspects, Social Disparities, Access to Healthcare, Quality of Life, and Knowledge About Menopause
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,592 (estimated)
- Sponsor
- Science Valley Research Institute · Academic / Other
- Sex
- All
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The Brazilian Registry of Menopausal Health is a national study aimed to better understand the health and quality of life of participants aged 35 to 65 who are in the menopausal transition or postmenopausal phase, including cisgender women and transgender men.The study's hypothesis is that significant regional and socioeconomic disparities influence individuals' health, knowledge, and perception of menopause.
Detailed description
The Brazilian Registry of Menopausal Health, called RENEW (Registry of ENdocrine Changes in midlifE Women), is an observational, cross-sectional, population-based study conducted with the objective of characterizing the epidemiological aspects of the Brazilian population during the menopausal transition and postmenopause, as well as the factors associated with clinical profiles and symptomatology, socioeconomic conditions, social inequalities, access to healthcare services, quality of life, and knowledge about menopause. The study will include cisgender women and transgender men who have not undergone surgical or hormonal gender reassignment of secondary sexual characteristics, aged between 35 and 65 years, who seek outpatient care in public or private healthcare services. A total of 1,592 participants will be enrolled, with 617, 509, and 466 participants in the respective age groups of 35-44, 45-54, and 55-65 years, proportionally stratified across the 27 state capitals of Brazil. These age groups will be used solely for the purpose of sample stratification.
Conditions
Timeline
- Start date
- 2025-11-17
- Primary completion
- 2026-05-01
- Completion
- 2026-06-01
- First posted
- 2025-06-05
- Last updated
- 2025-09-08
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT07005648. Inclusion in this directory is not an endorsement.